IL112074A - Thiazoles transformed by branched-chain amino groups, their preparation and pharmaceutical preparations containing them - Google Patents
Thiazoles transformed by branched-chain amino groups, their preparation and pharmaceutical preparations containing themInfo
- Publication number
- IL112074A IL112074A IL11207494A IL11207494A IL112074A IL 112074 A IL112074 A IL 112074A IL 11207494 A IL11207494 A IL 11207494A IL 11207494 A IL11207494 A IL 11207494A IL 112074 A IL112074 A IL 112074A
- Authority
- IL
- Israel
- Prior art keywords
- radical
- formula
- carbon atoms
- compounds
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9315386A FR2714059B1 (fr) | 1993-12-21 | 1993-12-21 | Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL112074A0 IL112074A0 (en) | 1995-03-15 |
| IL112074A true IL112074A (en) | 1998-12-06 |
Family
ID=9454174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11207494A IL112074A (en) | 1993-12-21 | 1994-12-20 | Thiazoles transformed by branched-chain amino groups, their preparation and pharmaceutical preparations containing them |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US5602132A (ja) |
| EP (1) | EP0659747B1 (ja) |
| JP (1) | JP3022223B2 (ja) |
| KR (1) | KR950017980A (ja) |
| CN (1) | CN1058964C (ja) |
| AT (1) | ATE164578T1 (ja) |
| AU (1) | AU685876B2 (ja) |
| CA (1) | CA2138638A1 (ja) |
| CZ (1) | CZ323094A3 (ja) |
| DE (1) | DE69409337T2 (ja) |
| DK (1) | DK0659747T3 (ja) |
| ES (1) | ES2115904T3 (ja) |
| FI (1) | FI945975A (ja) |
| FR (1) | FR2714059B1 (ja) |
| HU (1) | HUT71103A (ja) |
| IL (1) | IL112074A (ja) |
| NO (1) | NO304598B1 (ja) |
| NZ (1) | NZ270229A (ja) |
| PL (1) | PL306402A1 (ja) |
| RU (1) | RU2107063C1 (ja) |
| SI (1) | SI0659747T1 (ja) |
| TW (1) | TW401410B (ja) |
| ZA (1) | ZA9410196B (ja) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5795905A (en) * | 1995-06-06 | 1998-08-18 | Neurocrine Biosciences, Inc. | CRF receptor antagonists and methods relating thereto |
| FR2754258B1 (fr) * | 1996-10-08 | 1998-12-31 | Sanofi Sa | Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant |
| FR2796380B3 (fr) | 1999-07-15 | 2001-08-17 | Sanofi Synthelabo | Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant |
| TWI271406B (en) | 1999-12-13 | 2007-01-21 | Eisai Co Ltd | Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same |
| AU2001232271A1 (en) * | 2000-02-14 | 2001-08-20 | Japan Tobacco Inc. | Preventives/remedies for postoperative stress |
| EP1149583A3 (en) * | 2000-04-13 | 2001-11-14 | Pfizer Products Inc. | Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues |
| US6515005B2 (en) * | 2000-09-21 | 2003-02-04 | Bristol-Myers Squibb Company | Substituted azole derivatives as inhibitors of corticotropin releasing factor |
| TWI312347B (en) | 2001-02-08 | 2009-07-21 | Eisai R&D Man Co Ltd | Bicyclic nitrogen-containing condensed ring compounds |
| AU2002314744A1 (en) | 2001-04-17 | 2002-10-28 | Sepracor, Inc. | Thiazole and other heterocyclic ligands and use thereof |
| RU2308457C2 (ru) | 2001-04-27 | 2007-10-20 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Пиразоло [1, 5-а] пиридины и содержащие их лекарственные средства |
| ATE381542T1 (de) * | 2001-08-13 | 2008-01-15 | Phenex Pharmaceuticals Ag | Nr1h4-kern-rezeptor-bindende verbindungen |
| WO2003015777A1 (en) * | 2001-08-13 | 2003-02-27 | Lion Bioscience Ag | Nr1h4 nuclear receptor binding compounds |
| WO2003099849A2 (en) * | 2002-05-23 | 2003-12-04 | Michael Holick | Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy |
| TWI283679B (en) | 2002-10-22 | 2007-07-11 | Eisai Co Ltd | 7-phenylpyrazolopyridine compounds |
| US7176216B2 (en) | 2002-10-22 | 2007-02-13 | Eisai Co., Ltd. | 7-phenylpyrazolopyridine compounds |
| NZ588376A (en) | 2008-04-15 | 2011-06-30 | Eisai R&D Man Co Ltd | 3-phenylpyrazolo[5,1-b]thiazole compound having antagonism against corticotropin-releasing factor (CRF) receptor |
| AR078521A1 (es) | 2009-10-08 | 2011-11-16 | Eisai R&D Man Co Ltd | Compuesto pirazolotiazol |
| JPWO2011043387A1 (ja) * | 2009-10-08 | 2013-03-04 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピラゾロオキサゾール化合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3299087A (en) * | 1961-04-24 | 1967-01-17 | Geigy Chem Corp | Nu, nu'-bis-(thiazolyl)-phenylenediamines |
| FR2612187B1 (fr) * | 1987-03-12 | 1989-07-21 | Sanofi Sa | Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant |
| US5232921A (en) * | 1987-03-12 | 1993-08-03 | Sanofi | Thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions |
| DE3923675A1 (de) * | 1989-07-18 | 1991-01-24 | Basf Ag | Amonoalkylsubstituierte 2-aminothiazole und diese enthaltende therapeutische mittel |
| FR2656610B1 (fr) * | 1989-12-29 | 1992-05-07 | Sanofi Sa | Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique. |
| FR2692893B1 (fr) * | 1992-06-24 | 1994-09-02 | Sanofi Elf | Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
-
1993
- 1993-12-21 FR FR9315386A patent/FR2714059B1/fr not_active Expired - Fee Related
-
1994
- 1994-12-19 CZ CZ943230A patent/CZ323094A3/cs unknown
- 1994-12-19 TW TW083111880A patent/TW401410B/zh active
- 1994-12-20 CA CA002138638A patent/CA2138638A1/en not_active Abandoned
- 1994-12-20 SI SI9430138T patent/SI0659747T1/xx unknown
- 1994-12-20 JP JP6316765A patent/JP3022223B2/ja not_active Expired - Lifetime
- 1994-12-20 NO NO944946A patent/NO304598B1/no not_active IP Right Cessation
- 1994-12-20 AT AT94402954T patent/ATE164578T1/de active
- 1994-12-20 IL IL11207494A patent/IL112074A/en not_active IP Right Cessation
- 1994-12-20 PL PL94306402A patent/PL306402A1/xx unknown
- 1994-12-20 ES ES94402954T patent/ES2115904T3/es not_active Expired - Lifetime
- 1994-12-20 RU RU94044534A patent/RU2107063C1/ru active
- 1994-12-20 EP EP94402954A patent/EP0659747B1/fr not_active Expired - Lifetime
- 1994-12-20 FI FI945975A patent/FI945975A/fi unknown
- 1994-12-20 DE DE69409337T patent/DE69409337T2/de not_active Expired - Fee Related
- 1994-12-20 DK DK94402954T patent/DK0659747T3/da active
- 1994-12-20 HU HU9403690A patent/HUT71103A/hu unknown
- 1994-12-20 AU AU81632/94A patent/AU685876B2/en not_active Ceased
- 1994-12-21 US US08/360,351 patent/US5602132A/en not_active Expired - Fee Related
- 1994-12-21 CN CN94119558A patent/CN1058964C/zh not_active Expired - Fee Related
- 1994-12-21 ZA ZA9410196A patent/ZA9410196B/xx unknown
- 1994-12-21 KR KR1019940035536A patent/KR950017980A/ko active IP Right Grant
- 1994-12-21 NZ NZ270229A patent/NZ270229A/en unknown
-
1996
- 1996-11-27 US US08/756,402 patent/US5821255A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| TW401410B (en) | 2000-08-11 |
| KR950017980A (ko) | 1995-07-22 |
| ZA9410196B (en) | 1996-06-21 |
| RU94044534A (ru) | 1996-10-27 |
| ES2115904T3 (es) | 1998-07-01 |
| DE69409337D1 (de) | 1998-05-07 |
| NO944946L (no) | 1995-06-22 |
| FI945975A0 (fi) | 1994-12-20 |
| CA2138638A1 (en) | 1995-06-22 |
| JPH07224051A (ja) | 1995-08-22 |
| EP0659747B1 (fr) | 1998-04-01 |
| RU2107063C1 (ru) | 1998-03-20 |
| CN1127252A (zh) | 1996-07-24 |
| DK0659747T3 (da) | 1999-01-11 |
| NO304598B1 (no) | 1999-01-18 |
| CN1058964C (zh) | 2000-11-29 |
| HUT71103A (en) | 1995-11-28 |
| NO944946D0 (no) | 1994-12-20 |
| DE69409337T2 (de) | 1998-10-08 |
| EP0659747A1 (fr) | 1995-06-28 |
| NZ270229A (en) | 1996-04-26 |
| ATE164578T1 (de) | 1998-04-15 |
| SI0659747T1 (en) | 1998-08-31 |
| AU8163294A (en) | 1995-06-29 |
| FR2714059B1 (fr) | 1996-03-08 |
| CZ323094A3 (en) | 1995-07-12 |
| FR2714059A1 (fr) | 1995-06-23 |
| PL306402A1 (en) | 1995-06-26 |
| US5602132A (en) | 1997-02-11 |
| HU9403690D0 (en) | 1995-02-28 |
| JP3022223B2 (ja) | 2000-03-15 |
| AU685876B2 (en) | 1998-01-29 |
| FI945975A (fi) | 1995-06-22 |
| US5821255A (en) | 1998-10-13 |
| IL112074A0 (en) | 1995-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL112074A (en) | Thiazoles transformed by branched-chain amino groups, their preparation and pharmaceutical preparations containing them | |
| US4725610A (en) | Thiazolidinedione derivatives, their production and use | |
| US7396842B2 (en) | Five-membered cyclic compounds | |
| MXPA02005456A (es) | Derivados de oxazoles y tiazoles substituidos como activadores de hppar alfa. | |
| NZ247949A (en) | Branched alkylamino derivatives of thiazole, preparation and pharmaceutical compositions thereof | |
| CZ20033250A3 (en) | Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases | |
| JP2003503486A (ja) | 選択的ｎｐｙ（ｙ５）アンタゴニスト | |
| CA2664301A1 (en) | Fused ring compounds for inflammation and immune-related uses | |
| AU5731099A (en) | Substituted oxazoles and thiazoles derivatives as hppar gamma and hppar alpha activators | |
| NO811462L (no) | Fremgangsmaate ved fremstilling av aminothiadiazoler | |
| US20100240889A1 (en) | Urea Derivatives Methods For Their Manufacture And Uses Thereof | |
| CA2195559A1 (en) | Thiazolidinedione derivatives, their production and use | |
| US20100048891A1 (en) | Metasubstituted thiazolidinones, their manufacture and use as a drug | |
| JP2004517100A (ja) | ｈＰＰＡＲアルファアゴニストとしての置換オキサゾールおよびチアゾール | |
| JP4949582B2 (ja) | 新規アミノチアゾール誘導体、それらの製造およびそれらを含有する医薬組成物 | |
| DE102005005395A1 (de) | Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel | |
| JPH11503121A (ja) | アミジン誘導体 | |
| RU2360907C2 (ru) | Производные ациламинотиазола, их получение и их применение в качестве ингибиторов продукции бета-амилоидного пептида | |
| WO1999033827A1 (fr) | Nouveaux derives d'imidazole | |
| DAHLBOM | Antihistamine Agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| HC | Change of name of proprietor(s) | ||
| MM9K | Patent not in force due to non-payment of renewal fees |